Announcements
Read our newly accepted comprehensive review on COVID-19, the first of a 3 part series!!
Recently accepted COV-IRT member led comprehensive review of intracellular drivers in SARS-CoV-2 Infection Read the first review of a 3 part COVID-19 review series led by COV-IRT members. This first review focuses on what is [...]
Read our newly accepted from COV-IRT on how lncRNAs are involved with SARS-CoV-2 infections!!
Read our newly accepted paper on the impact of lncRNAs with SARS-CoV-2 infection! This work was driven by COV-IRT member Dr. Francisco J. Enguita! Click here to download and read the paper:
Read the new preprint on the COVID-19 Exposures Assessment Tool (CEAT)!!!
Covid-19 Exposure Assessment Tool (CEAT): Easy-to-use tool to quantify exposure based on airflow, group behavior, and infection prevalence in the community A new preprint is available from COV-IRT members that is on our COVID-19 Exposure [...]
Targeted Down Regulation Of Core Mitochondrial Genes During SARS-CoV-2 Infection
New Preprint from COV-IRT members on a large comprehensive study on how Mitochondrial Functions are Suppressed In COVID-19 Patients!! Click on the following link for the preprint on bioRxiv:
A New Version of our COVID-19 Exposure Assessment Tool (CEAT) has Just Been Released!!
A New Version of our COVID-19 Exposure Assessment Tool (CEAT) has Just Been Released!! There is a new and improved version of CEAT available now for download. The new and improved now includes estimates [...]
A Unique Collaboration
This unique collaborative team brings together all the capabilities needed to address the COVID-19 pandemic – computational expertise, clinical experience, advanced laboratory proficiency, and a deep knowledge of human and coronavirus genetics.
COV-IRT Project Goals:
Enhance public datasets to reveal host infection dynamics for SARS-CoV-2 to improve medical treatment options for COVID-19 patients.
Determine and design optimal targets for therapeutics against SARS-CoV-2
Creating new drug delivery systems based on targets
Test newly developed therapeutics in both in vitro and in vivo SARS-CoV-2 models
Apply for human clinical trials
Team Members
COV-IRT was founded by Dr. Afshin Beheshti, Dr. Todd Treangen, and Dr. Krista Ternus and is led by Dr. Beheshti. Members include scientists and experts from across the world, directors from both academic institutions and hospitals, senior and junior faculty, leaders from industry, graduate students, and postdocs.
The Latest from the Newsroom
The COVID-19 International Research Team is already producing interesting analyses that can potentially bring mechanistic understanding of SARS-CoV-2 and help identify therapies. Visit the Newsroom for media coverage, research updates, upcoming events, and resources.
Read our newly accepted comprehensive review on COVID-19, the first of a 3 part series!!
Recently accepted COV-IRT member led comprehensive review of intracellular drivers in SARS-CoV-2 Infection Read the first review of a 3 part COVID-19 review series led by COV-IRT members. This first review focuses on what is [...]
Read our newly accepted from COV-IRT on how lncRNAs are involved with SARS-CoV-2 infections!!
Read our newly accepted paper on the impact of lncRNAs with SARS-CoV-2 infection! This work was driven by COV-IRT member Dr. Francisco J. Enguita! Click here to download and read the paper:
Read the new preprint on the COVID-19 Exposures Assessment Tool (CEAT)!!!
Covid-19 Exposure Assessment Tool (CEAT): Easy-to-use tool to quantify exposure based on airflow, group behavior, and infection prevalence in the community A new preprint is available from COV-IRT members that is on our COVID-19 Exposure [...]